Back to news archive
Image for Medtech4Health grants for strategic innovation in healthcare
Grants & Awards 2016-06-08

Medtech4Health grants for strategic innovation in healthcare

Gradientech together with the EUCAST Reference Laboratory (European Committee on Antimicrobial Susceptibility Testing) receive 1,3 mkr in  Medtech4Health grants for verification of the diagnostic solution for ulta-rapid antibiotic susceptibility testing currently in development by Gradientech.

Medtech4Health is the new innovation program approved by the Swedish Innovation Agency last year, aiming to strengthen collaborations between academia, health care and industry to result in improved health solutions.

Link to press-release

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book